Reducing the costs of chronic kidney disease while delivering quality health care: a call to action

Nature Reviews Nephrology 13, 393 (2017). doi:10.1038/nrneph.2017.63 Authors: Raymond Vanholder, Lieven Annemans, Edwina Brown, Ron Gansevoort, Judith J. Gout-Zwart, Norbert Lameire, Rachael L. Morton, Rainer Oberbauer, Maarten J. Postma, Marcello Tonelli, Wim Van Biesen & Carmine Zoccali The treatment of chronic kidney disease (CKD) and of end-stage renal disease (ESRD) imposes substantial societal costs. Expenditure is highest for renal replacement therapy (RRT), especially in-hospital haemodialysis. Redirection towards less expensive forms of RRT (peritoneal dialysis, home haemodialysis) or kidney transplantation should decrease financial
Source: Nature Reviews Nephrology - Category: Urology & Nephrology Authors: Tags: Review Source Type: research